Giles Lisa M. 4
4 · HCW Biologics Inc. · Filed Jun 17, 2024
Insider Transaction Report
Form 4
Giles Lisa M.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-14+12,500→ 12,500 totalExercise: $1.12Exp: 2025-06-13→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1](1) 100% of the total number of shares subject to the Option shall vest and become exercisable on the earlier of (a) June 13, 2025 or (b) the next annual meeting of stockholders, subject to the Reporting Person continuing to provide services through the vesting date.